Gung ho: Alnylam lands historic FDA OK on patisiran, revving up the first global rollout for an RNAi breakthrough
“A lot of people think it’s winter out there for RNAi. But I think it’s springtime.” — Alnylam CEO John Maraganore, NYT, February 7 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
